CAND1 Antikörper (AA 1-100)
-
- Target Alle CAND1 Antikörper anzeigen
- CAND1 (Cullin-Associated and Neddylation-Dissociated 1 (CAND1))
-
Bindungsspezifität
- AA 1-100
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CAND1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant CAND1.
- Sequenz
- MASASYHISN LLEKMTSSDK DFRFMATNDL MTELQKDSIK LDDDSERKVV KMILKLLEDK NGEVQNLAVK CLGPLVSKVK EYQVETIVDT LCTNMLSDKE
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- CAND1 (NP_060918, 1 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 5D7
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer." in: Neoplasia (New York, N.Y.), Vol. 14, Issue 9, pp. 799-806, (2012) (PubMed).
: "
-
CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer." in: Neoplasia (New York, N.Y.), Vol. 14, Issue 9, pp. 799-806, (2012) (PubMed).
-
- Target
- CAND1 (Cullin-Associated and Neddylation-Dissociated 1 (CAND1))
- Andere Bezeichnung
- CAND1 (CAND1 Produkte)
- Hintergrund
-
Full Gene Name: cullin-associated and neddylation-dissociated 1
Synonyms: DKFZp434M1414,FLJ10114,FLJ10929,FLJ38691,FLJ90441,KIAA0829,TIP120,TIP120A - Gen-ID
- 55832
- NCBI Accession
- NM_018448
- Pathways
- Regulation of Actin Filament Polymerization
-